
In August a compounding pharmacy in Austin, Texas voluntarily recalled three lots of injectable glutathione after testing found elevated endotoxin levels. Patients had reported nausea, vomiting, tachycardia, which means a racing heart, and reactions at the injection site.
The FDA language around this is unusually blunt. Anaphylactic shock and death are associated with high endotoxin levels in injectable products.
Glutathione is a tripeptide, three amino acids joined together, sold widely in wellness clinics. But the specific product matters less than the failure mode, because this one can affect any injectable peptide and most people buying them have never heard of it.
Endotoxins are fragments of the outer wall of certain bacteria. Here is the part that surprises people:
Killing the bacteria does not remove them.
An endotoxin is not alive. It is a piece of molecular debris, and it is remarkably heat stable. You can sterilize a solution, destroy every living organism in it, and be left with a perfectly sterile liquid that still carries enough bacterial fragments to make someone quite ill. Your immune system recognizes those fragments as evidence of infection and mounts a response accordingly, which is why the symptoms look like a sudden illness: fever, chills, nausea, a racing heart.
So sterile and safe are not the same claim. A product can pass a sterility test and fail an endotoxin test. They are measured separately, endotoxins by a specific assay that has nothing to do with culturing bacteria.
This connects directly to something we wrote about this week, when a peptide vendor was sentenced over forged lab certificates. There the problem was fake documents. Here the problem is real documents that measure the wrong thing.
A standard purity certificate reports chromatography and mass spectrometry results. Those answer two questions: is this the molecule it claims to be, and what proportion of the contents is that molecule. Both are worth knowing.
Neither detects bacterial contamination. A vial can be 99 percent pure peptide by chromatography and still contain enough endotoxin to send someone to hospital, because the endotoxin is part of the remaining fraction that the test was never designed to characterize.
If you have been treating a purity percentage as a general safety score, this is the gap in that reasoning.
Between this year's cases there are now three distinct failure modes on record, and they have almost nothing to do with each other.
A product can be flawless on two of these and still harm someone through the third. Any single test or certificate covers one of them at best.
Glutathione does not have FDA approval for compounding under the rules governing this type of pharmacy, and holds only a dietary supplement designation rather than a pharmaceutical one. This is not the first time it has caused trouble either. An endotoxin outbreak in 2019 already prompted regulators to warn against compounding it for injection.
A known problem, a prior warning, and a repeat seven years later is a reasonable thing to be annoyed about.
If you inject any compounded peptide:
None of this means compounded products are inherently unsafe. A licensed compounding pharmacy operating properly is a considerably better source than an anonymous website, which is the whole argument behind the current regulatory push. It means that safety is made of several separate things, and buying the one that gets advertised does not get you the others.
Source: Partnership for Safe Medicines: compounded peptide injections recalled over high endotoxin levels.
Written by
Dr. Anna Chereshnevskyi
General Practitioner
Dr. Chereshnevskyi is a general practitioner who graduated from Lviv National Medical University and currently practices at a state hospital in Ankara, Turkey. She specialises in primary care and follows the clinical literature on peptide therapies, metabolic health, and longevity research. She contributes to Peptide.pub as a medical reviewer and blog author, translating complex research into plain, evidence-based language.
About Peptide.pub →